Identification of a Patient Suitable for CAR-T Cell Therapy in the Outpatient Setting: A Vodcast and Case Example

Abstract Chimeric antigen receptor T cell (CAR-T) therapies targeting the CD19 antigen have been associated with high and durable response rates in patients with diffuse large B cell lymphoma (DLBCL). CAR-T cell therapies are commonly administered in the inpatient setting due to the average onset of...

Full description

Saved in:
Bibliographic Details
Main Authors: Ronan Foley, John Kuruvilla
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-04-01
Series:Oncology and Therapy
Subjects:
Online Access:https://doi.org/10.1007/s40487-024-00272-9
Tags: Add Tag
No Tags, Be the first to tag this record!